NCT06481254

Brief Summary

In this context, this study investigated the quality of life related to oral mucositis and oral health in patients with DM using hawthorn vinegar, black mulberry syrup and green tea.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 6, 2024

Completed
7 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 13, 2024

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 23, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 1, 2024

Completed
Last Updated

November 18, 2025

Status Verified

November 1, 2025

Enrollment Period

7 days

First QC Date

June 23, 2024

Last Update Submit

November 14, 2025

Conditions

Keywords

Hawthorn vinegarBlack mulberry syrupMucositisGreen teaQuality of life.

Outcome Measures

Primary Outcomes (2)

  • Oral Assessment Guide (OAG)

    The "OAG" is useful for assessing and recording the individual's daily oral condition, as well as detecting the presence of mucositis and evaluating the effectiveness of treatment. The "OAG" consists of 8 categories including voice, dysphagia, lips, tongue, saliva, mucous membranes, gums and teeth/prostheses. "OAG" was administered again on the 7th day (interim-measurement) and 14th day/end of the study (post-test).

    14 Days

  • Oral Health Related Quality of Life Scale (OHQoL-UK)

    The 5-point Likert-type scale, which consists of a total of 16 items to determine the degree of impact of teeth, gums, mouth or prosthesis, consists of 4 dimensions: "symptom" (items 1-2), "physical condition" (items 3-7), "psychological condition" (items 8-12) and "social condition" (items 13-16). Each item in the scale is scored as "Very bad effect-1, bad effect-2, no effect-3, good effect-4, very good effect-5". The total score of the scale varies between 16-80, and a high score indicates a high level of oral and dental health-related quality of life. The Cronbach alpha value of the scale was reported as 0.94. "OHQoL-UK" was administered again on the 7th day (interim-measurement) and 14th day/end of the study (post-test).

    14 Days

Study Arms (4)

Hawthorn Vinegar Group

EXPERIMENTAL

Before starting the study (pre-test/0. week), "Patient Information Form", "OAG" and "OHQoL-UK" were administered to all group participants to evaluate the level of oral mucositis in patients. In addition to routine oral mucositis treatment, patients with DM in the hawthorn vinegar group gargled with 1 tablespoon (10 cc) of diluted hawthorn vinegar (mixed with 40 cc water) for 1 minute 15-20 minutes before meals 3 times a day for 14 days. "OAG" and "OHQoL-UK" were administered again on the 7th day (interim-measurement) and 14th day/end of the study (post-test).

Other: Hawthorn Vinegar Group

Black Mulberry Syrup Group

EXPERIMENTAL

Before starting the study (pre-test/0. week), "Patient Information Form", "OAG" and "OHQoL-UK" were administered to all group participants to evaluate the level of oral mucositis in patients. In addition to routine oral mucositis treatment, patients with DM in the black mulberry syrup group gargled with 1 tablespoon (10 cc) of pure black mulberry syrup for 1 minute 15-20 minutes before meals 3 times a day for 14 days. "OAG" and "OHQoL-UK" were administered again on the 7th day (interim-measurement) and 14th day/end of the study (post-test).

Other: Black Mulberry Syrup Group

Green Tea Group

EXPERIMENTAL

Before starting the study (pre-test/0. week), "Patient Information Form", "OAG" and "OHQoL-UK" were administered to all group participants to evaluate the level of oral mucositis in patients. In addition to routine oral mucositis treatment, patients with DM in the green tea group gargled with 50 cc green tea for 1 minute 15-20 minutes before meals 3 times a day for 14 days. "OAG" and "OHQoL-UK" were administered again on the 7th day (interim-measurement) and 14th day/end of the study (post-test).

Other: Green Tea Group

Control Group

NO INTERVENTION

Patients in the control group received no any treatment other than routine oral mucositis treatment and data collection tools. "Patient Information Form", "OAG" and "OHQoL-UK" were administered to the patients before the study (pre-test/0th week) and "OAG" and "OHQoL-UK" were administered again on the 7th day (mid-measurement) and 14th day/end of the study (post-test).

Interventions

To routine oral mucositis treatment, patients with DM in the hawthorn vinegar group gargled with 1 tablespoon (10 cc) of diluted hawthorn vinegar (mixed with 40 cc water) for 1 minute 15-20 minutes before meals 3 times a day for 14 days.

Hawthorn Vinegar Group

To routine oral mucositis treatment, patients with DM in the black mulberry syrup group pure black mulberry syrup for 1 minute 15-20 minutes before meals 3 times a day for 14 days.

Black Mulberry Syrup Group

To routine oral mucositis treatment, patients with DM in the green tea group gargled with 50 cc green tea for 1 minute 15-20 minutes before meals 3 times a day for 14 days.

Green Tea Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Overs 18 years of age,
  • Voluntary participation in the study,
  • Be lucid and able to communicate,
  • Be diagnosed with DM for at least 3 months ago,
  • Willing to use either hawthorn vinegar, black mulberry syrup or green tea as a complementary treatment for oral mucositis,
  • HbA1c ≥ 7% (Wang and Hng, 2021),
  • Oral mucositis score of 14\< in oral assessment.

You may not qualify if:

  • Having a known psychological disorder,
  • Having HbA1c \<7%,
  • Not having oral mucositis,
  • Having hearing loss.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gümüşhane University

Gümüşhane, 29600, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Mucositis

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesMouth DiseasesStomatognathic Diseases

Study Officials

  • Hatice Demirağ, Dr.Öğr.Üyesi

    Study Principal Investigator Gümüşhane Universıty

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
The principal investigator completed the consent and assent forms after explaining the purpose of the study to all participants. In the research planned as a single-blind randomized controlled clinical study, the other researcher who applied the data collection tools to reduce bias was not told who the experimental groups (hawthorn vinegar group, black mulberry syrup group, green tea group) and the patients with DM in the control group were.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The sample size of the study was calculated as 128 individuals in total (32 for each group) for 4 groups (hawthorn vinegar, black mulberry syrup, green tea, control group) with an effect size of 0.25 with α=0.05 and the power of the targeted test was 0.80 (80%) in the G\*Power 3.1.9.7 program, which could not be used as a reference since there was no previous four-group study on the subject. Each group was increased to account for drop-outs and deaths and a total of 140 individuals, 35 for each group, were included in the study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

June 23, 2024

First Posted

July 1, 2024

Study Start

February 6, 2024

Primary Completion

February 13, 2024

Study Completion

February 20, 2024

Last Updated

November 18, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations